{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:18:51Z","timestamp":1792149531382,"version":"4.4.0"},"reference-count":43,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"DOI":"10.1210\/jc.2012-3873","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T02:59:37Z","timestamp":1360810777000},"page":"1443-1449","source":"Crossref","is-referenced-by-count":273,"title":["Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center"],"prefix":"10.1210","volume":"98","author":[{"given":"M. L.","family":"Tanda","sequence":"first","affiliation":[{"name":"Section of Endocrinology (M.L.T., E.P., L.L., A.L., L.S., N.P., D.G., L.B.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Piantanida","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (M.L.T., E.P., L.L., A.L., L.S., N.P., D.G., L.B.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Liparulo","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (M.L.T., E.P., L.L., A.L., L.S., N.P., D.G., L.B.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Veronesi","sequence":"additional","affiliation":[{"name":"Research Center in Epidemiology and Preventive Medicine (EPIMED) (G.V., M.F.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lai","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (M.L.T., E.P., L.L., A.L., L.S., N.P., D.G., L.B.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sassi","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (M.L.T., E.P., L.L., A.L., L.S., N.P., D.G., L.B.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pariani","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (M.L.T., E.P., L.L., A.L., L.S., N.P., D.G., L.B.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gallo","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (M.L.T., E.P., L.L., A.L., L.S., N.P., D.G., L.B.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Azzolini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine; and Department of Surgical and Morphological Sciences (C.A.), University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ferrario","sequence":"additional","affiliation":[{"name":"Research Center in Epidemiology and Preventive Medicine (EPIMED) (G.V., M.F.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bartalena","sequence":"additional","affiliation":[{"name":"Section of Endocrinology (M.L.T., E.P., L.L., A.L., L.S., N.P., D.G., L.B.), 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113342843400_B1","first-page":"168","article-title":"Management of Graves' ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113342843400_B2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1210\/jc.2012-3119","article-title":"Public health relevance of Graves' orbitopathy","volume":"98","author":"Ponto","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113342843400_B4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF03346614","article-title":"Pathogenesis of Graves' orbitopathy: a 2010 update","volume":"33","author":"Smith","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113342843400_B5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/105072502761016476","article-title":"Epidemiology and prevention of Graves' ophthalmopathy","volume":"12","author":"Wiersinga","year":"2002","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113342843400_B6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1530\/eje.0.1460457","article-title":"Graves' ophthalmopathy: a preventable disease?","volume":"146","author":"Bartalena","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113342843400_B7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2011.09.004","article-title":"Prevention of Graves' ophthalmopathy","volume":"26","author":"Bartalena","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B8","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves' orbitopathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113342843400_B9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113342843400_B10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMcp0806317","article-title":"Clinical practice: Graves' ophthalmopathy","volume":"360","author":"Bartalena","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113342843400_B11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000320437","article-title":"Rehabilitative surgery","volume-title":"Graves' Orbitopathy: A Multidisciplinary Approach, Questions and Answers","author":"Baldeschi","year":"2010","edition":"2nd rev ed"},{"key":"key\n\t\t\t\t2019041113342843400_B12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.beem.2011.11.002","article-title":"Surgical treatment of Graves' ophthalmopathy","volume":"26","author":"Eckstein","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2011.10.005","article-title":"Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease","volume":"26","author":"Lazarus","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1995.tb02597.x","article-title":"Natural history of thyroid associated ophthalmopathy","volume":"42","author":"Perros","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113342843400_B15","first-page":"603","article-title":"Graves' ophthalmopathy: natural history and treatment outcomes","volume":"131","author":"Noth","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"key\n\t\t\t\t2019041113342843400_B16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2265.1998.00487.x","article-title":"Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey","volume":"49","author":"Weetman","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113342843400_B17","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2012-1275","article-title":"Incidence and clinical presentation of moderate to severe Graves' orbitopathy in a Danish population before and after iodine fortification of salt","volume":"97","author":"Laurberg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2265.1999.00843.x","article-title":"The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study","volume":"51","author":"Marcocci","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113342843400_B19","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113342843400_B20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113342843400_B21","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"Tr\u00e4isk","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B22","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM198911163212001","article-title":"Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism","volume":"321","author":"Bartalena","year":"1989","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113342843400_B23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jc.2009-2130","article-title":"Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study","volume":"95","author":"Lai","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/thy.1998.8.423","article-title":"Natural history of thyroid eye disease","volume":"8","author":"Perros","year":"1998","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113342843400_B25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113342843400_B26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2010-2329","article-title":"The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy","volume":"96","author":"Bartalena","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B27","first-page":"185","article-title":"Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism","volume":"121","author":"Prummel","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"key\n\t\t\t\t2019041113342843400_B28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archinte.1990.00390170124027","article-title":"Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy","volume":"150","author":"Prummel","year":"1990","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113342843400_B29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1530\/eje.0.1300494","article-title":"Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment?","volume":"130","author":"Tallstedt","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113342843400_B30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bmj.295.6599.634","article-title":"Is endocrine ophthalmopathy related to smoking?","volume":"295","author":"H\u00e4gg","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key\n\t\t\t\t2019041113342843400_B31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF03350047","article-title":"More on smoking habits and Graves' ophthalmopathy","volume":"12","author":"Bartalena","year":"1989","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113342843400_B32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1993.03500040045034","article-title":"Smoking and risk of Graves' disease","volume":"269","author":"Prummel","year":"1993","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113342843400_B33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1530\/acta.0.1280156","article-title":"Graves' disease, endocrine ophthalmopathy and smoking","volume":"128","author":"Winsa","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"key\n\t\t\t\t2019041113342843400_B34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/eje.0.1330507","article-title":"Cigarette smoking and the thyroid","volume":"133","author":"Bartalena","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113342843400_B35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","article-title":"Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption","volume":"45","author":"Pfeilschifter","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113342843400_B36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/thy.2011.0039","article-title":"Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy","volume":"21","author":"Laurberg","year":"2011","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113342843400_B37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/thy.2010.0181","article-title":"Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy","volume":"21","author":"Elbers","year":"2011","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113342843400_B38","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2006-1800","article-title":"Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids","volume":"92","author":"Menconi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B39","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1210\/jc.2011-2077","article-title":"Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trial","volume":"97","author":"Leo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342843400_B40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12020-011-9559-x","article-title":"Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study","volume":"41","author":"De Bellis","year":"2012","journal-title":"Endocrine"},{"key":"key\n\t\t\t\t2019041113342843400_B41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2265.2008.03417.x","article-title":"Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions","volume":"69","author":"Tanda","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113342843400_B42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000320432","article-title":"Combined thyroid-eye clinics","volume-title":"Graves' Orbitopathy: A Multidisciplinary Approach, Questions and Answers","author":"Wiersinga","year":"2010","edition":"2nd rev ed"},{"key":"key\n\t\t\t\t2019041113342843400_B43","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","article-title":"Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy","volume":"97","author":"Bartalena","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/4\/1443\/9045732\/jcem1443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T18:33:27Z","timestamp":1562697207000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/4\/1443\/2536784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-3873","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]}}}